MedTrace Logo

Effects and Cost-effectiveness of e-Meistring - a Guided Internet-delivered Psychological Treatment

NCT05868135 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2025-06-05

No results posted yet for this study

Summary

The goal of this observational multicentre study is to address the effectiveness and cost-effectiveness of providing a therapist guided internet based cognitive behavioural therapy (ICBT) for common mental disorders in a routine healthcare setting.

Main research questions is 1) What is the effectiveness of guided internet based treatment for moderate depression, panic disorder and social anxiety disorder across clinics in routine care? 2) What is the cost-effectiveness of guided internet based treatment for moderate depression, panic disorder and social anxiety disorder across clinics? 3) Who benefits from guided internet-delivered treatment? 4) What are the predictors of drop-out from guided internet based treatment? 5) To what extent does user experiences of guided internet based treatment influence adherence and effectiveness? Participants will receive up to nine guided ICBT sessions (modules) and answer questionnaires covering symptoms severity, health related quality of life, work and social ability, user satisfaction and medication. All questionnaires are part of the standard patient follow up routines in the four treatment locations participating in the study. Analytical approach is to compare locations/clinics and subgroups of patients.

Conditions

  • Depression Moderate
  • Anxiety, Social
  • Panic Disorder

Interventions

BEHAVIORAL

eMeistring

Initial face-to-face visit, eight/nine sessions/modules of therapist guided ICBT, final face-to-face visit

Sponsors & Collaborators

  • Haukeland University Hospital

    collaborator OTHER

  • The Hospital of Vestfold

    collaborator OTHER

  • Sykehuset Innlandet HF

    collaborator OTHER

  • St. Olavs Hospital

    lead OTHER

Principal Investigators

  • Elin T Ulleberg, Master · St. Olavs Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-09
Primary Completion
2026-07-31
Completion
2027-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05868135 on ClinicalTrials.gov